세계의 종양 용해성 바이러스 요법 시장 : 제품 유형별, 용도별, 개발 단계별, 유통 채널별, 지역별
Oncolytic Virus Therapy Market, By Product Type, By Application , By Development Stage, By Distribution Channel, By Region
상품코드
:
1741186
리서치사
:
Coherent Market Insights
발행일
:
2025년 03월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
세계의 종양 용해성 바이러스 요법 시장은 2025년 1,780만 달러로 추정되고, 2032년까지 8,730만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지 CAGR 25.5%로 성장할 전망입니다.
| 보고 범위 |
보고서 세부정보 |
| 기준연도 |
2024년 |
2025년 시장 규모 |
1,780만 달러 |
| 실적 데이터 |
2020-2024년 |
예측 기간 |
2025-2032년 |
| 예측 기간: 2025-2032년 CAGR |
25.50% |
2032년 금액 예측 |
8,730만 달러 |
종양 용해성 바이러스 요법은 암 치료의 유망한 접근법으로, 변형 바이러스를 이용하여 건강한 세포를 온존하면서 암세포를 선택적으로 표적으로 파괴합니다. 이 부문은 1990년대에 유전공학의 진보와 함께 기세를 늘렸고, 과학자들은 바이러스를 변경하여 종양 특이성과 치료 효과를 높일 수 있게 되었습니다. 암세포에 감염하여 그 안에서 복제하여 세포용해를 유도하거나 종양에 대한 면역반응을 자극하거나 할 수 있습니다.
시장 역학
세계의 종양 용해성 바이러스 요법 시장은 바이러스 공학의 진보, 암 생물학에 대한 이해의 깊어짐, 임상 검사의 성공, 혁신적인 암 치료의 필요성 등으로부터 강력한 성장을 이루고 있습니다. 나암 적응증의 탐색, 치료 성적 향상을 위한 병용 요법, 맞춤형 의료 접근, 특성을 강화한 차세대 바이러스의 개발은 가까운 미래에 밝은 시장 기회를 가져올 것으로 기대되고 있습니다. 2023년 6월 29일, Genelux Corporation과 TVAX Biomedical, Inc.는 미국 특허 상표청이 백신 강화 입양 T 세포 요법과 온콜리틱 바이러스 보조 요법을 결합하는 방법을 주장하는 특허를 부여했다고 발표했습니다. 특허 기간 연장 전의 특허 만료는 2036년으로 V2ACT 면역 요법에 실질적인 지적 재산권 보호가 추가됩니다.
그러나 제한된 임상 증거, 배달 및 유통 문제, 치료와 관련된 고가의 비용, 치료 부작용 등이 시장 성장을 방해할 것으로 예측됩니다.
본 조사의 주요 특징
- 본 보고서에서는 세계의 종양 용해성 바이러스 요법 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간 2025-2032년 시장 규모와 CAGR을 제공합니다.
- 또, 다른 부문에 걸친 잠재적인 수익 기회를 해명해, 이 시장의 매력적인 투자 제안 매트릭스를 해설했습니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시나 승인, 시장 동향, 지역에 의한 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 주요 고찰도 제공합니다.
- 본 보고서에서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 파라미터를 바탕으로 세계의 암 용해성 바이러스 요법 시장에서 주요 기업 프로파일을 제공합니다.
- 본 보고서로부터 통찰에 의해 마케팅 담당자나 기업의 경영진은 장래의 제품 출시, 유형, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시할 수 있습니다.
- 이 조사 보고서는 투자자, 공급업체, 제품 제조업체, 판매자, 신규 참가자, 재무 분석가 등이 산업의 다양한 이해 관계자를 대상으로 합니다.
- 이해관계자는 세계의 종양 용해성 바이러스 요법 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사의 목적과 전제조건
제2장 시장 전망
- 보고서 설명
- 주요 요약
- Coherent Opportunity Map (COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 바이러스 공학의 진보
- 암 생물학의 이해를 깊게
- 임상검사의 성공예
- 혁신적인 암 치료의 필요성
- 치료에 드는 고액의 비용
- 치료의 부작용
- 새로운 암 적응증의 탐색
- 치료를 조합하여 성과를 향상
- 맞춤형 의료 접근
- 영향 분석
- 규제 시나리오
- 제품 출시/승인
- PEST 분석
- Porter's Five Forces 분석
- 합병과 인수 시나리오
제4장 종양 용해성 바이러스 요법 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
- COVID-19 역학
- 공급측과 수요측의 분석
- 경제에 미치는 영향
제5장 종양 용해성 바이러스 요법 시장 : 제품 유형별, 2020-2032년
- 소개
- 단순 헤르페스 바이러스
- 아데노바이러스
- 백시니아 바이러스
- 레오바이러스
- 홍역 바이러스
- 기타(뉴캐슬병 바이러스, 수포성 구내염 바이러스)
제6장 종양 용해성 바이러스 요법 시장 : 용도별, 2020-2032년
- 소개
- 흑색종
- 유방암
- 두경부암
- 방광암
- 전립선암
- 폐암
- 기타(대장암 등)
제7장 종양 용해성 바이러스 요법 시장 : 개발 단계별, 2020-2032년
- 소개
- 상용
- 파이프라인 단계
- 전임상
- 페이즈 I
- 페이즈 II
- 페이즈 III
제8장 종양 용해성 바이러스 요법 시장 : 유통 채널별, 2020-2032년
제9장 종양 용해성 바이러스 요법 시장 : 지역별, 2020-2032년
- 소개
- 북미
- 유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 일본
- 인도
- 호주
- 한국
- ASEAN 국가
- 기타 아시아태평양
- 라틴아메리카
- 중동
- 아프리카
제10장 경쟁 구도
- Amgen Inc.
- Merck & Co., Inc.
- Oncolytics BIoTech Inc.
- Circio Holding ASA
- Akamis Bio
- Vyriad, Inc.
- SillaJen BIoTherapeutics
- Cold Genesys Inc.
- Sorrento Therapeutics, Inc.
- Takara Bio Inc.
- Replimune Group Inc.
- Genelux Corporation
- Synthetic Biologics, Inc
- Lokon Pharma AB
- Elicera Therapeutics
제11장 섹션
JHS
영문 목차
Oncolytic Virus Therapy Market is estimated to be valued at USD 17.8 Mn in 2025 and is expected to reach USD 87.3 Mn by 2032, growing at a compound annual growth rate (CAGR) of 25.5% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 17.8 Mn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
25.50% |
2032 Value Projection: |
USD 87.3 Mn |
Oncolytic virus therapy is a promising approach to cancer treatment that utilizes modified viruses to selectively target and destroy cancer cells while sparing healthy cells. The concept for viruses for cancer treatment dates back to the early 20th century, when researchers observed tumor regression in patients with viral infections. The field gained momentum in the 1990s with advancements in genetic engineering, enabling scientists to modify viruses to enhance the tumor-specificity and therapeutic efficacy. Oncolytic viruses can infect cancer cells, replicate within them, and induce cell lysis or stimulate immune responses against the tumor. Ongoing research focuses on optimizing viral platforms, developing combination therapies, and expanding the application of oncolytic virus therapy to various cancer types. Collaborations between academia, pharmaceutical companies, and research institutions drive the development of novel oncolytic virus therapies and hold promise for advancing cancer treatment approaches.
Market Dynamics:
The global oncolytic virus therapy market is witnessing strong growth on account of growing advancements in viral engineering, increasing understanding of cancer biology, successful clinical trial results, and the need for innovative cancer treatments. Moreover, exploring new cancer indications, combining therapies for improved outcomes, personalized medicine approaches, and the development of next-generation viruses with enhanced characteristics are expected to bring bright market opportunities in the near future. The market trends include advancements in virotherapy platforms, targeted delivery systems, immune modulation strategies, and addressing manufacturing and commercialization challenges in the field. Moreover, market players are focused on developing novel drugs by collaborating, which is expected to drive the growth of global oncolytic virus therapy market. For instance, on June 29, 2023, Genelux Corporation, a late clinical-stage biopharmaceutical company, and TVAX Biomedical, Inc., a late clinical-stage biopharmaceutical company, announced that the U.S. Patent and Trademark Office granted a patent claiming methods of combining vaccine-enhanced adoptive T cell therapy with oncolytic virus adjunct therapy. The patent has been exclusively licensed to V2ACT Therapeutics, LLC, a joint venture between Genelux and TVAX that was established for the purpose of developing and testing V2ACT immunotherapy. The patent expiry, prior to any patent term extension, will be in 2036 and will add substantial intellectual property protection for V2ACT immunotherapy.
However, limited clinical evidence, delivery and distribution challenges, high costs associated with treatment, and side effects of treatment are expected to hamper market growth. Overcoming these challenges is essential to maximizing the efficiency and broader adoption of oncolytic virus therapies.
Key features of the study:
- This report provides in-depth analysis of the global oncolytic virus therapy market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global oncolytic virus therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study Amgen Inc., Merck & Co., Inc., Oncolytics Biotech Inc., Circio Holding ASA, Akamis Bio, Vyriad, Inc., SillaJen Biotherapeutics, Cold Genesys Inc., Sorrento Therapeutics, Inc., Takara Bio Inc., Replimune Group Inc., Genelux Corporation, Synthetic Biologics, Inc., Lokon Pharma AB, and Elicera Therapeutics.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global oncolytic virus therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oncolytic virus therapy market
Detailed Segmentation:
- Global Oncolytic Virus Therapy Market, By Product Type:
- Herpes simplex virus
- Adenovirus
- Vaccinia virus
- Reovirus
- Measles virus
- Others (Newcastle disease virus, Vesicular stomatitis virus)
- Global Oncolytic Virus Therapy Market, By Application:
- Melanoma
- Breast cancer
- Head and neck cancer
- Bladder Cancer
- Prostate Cancer
- Lung Cancer
- Others (Colorectal Cancer, and among Others)
- Global Oncolytic Virus Therapy Market, By Development Stage:
- Commercial
- Pipeline Phase
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Global Oncolytic Virus Therapy Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Oncolytic Virus Therapy Market, By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
- Company Profiles:
- Amgen Inc.
- Merck & Co., Inc.
- Oncolytics Biotech Inc.
- Circio Holding ASA
- Akamis Bio
- Vyriad, Inc.
- SillaJen Biotherapeutics
- Cold Genesys Inc.
- Sorrento Therapeutics, Inc.
- Takara Bio Inc.
- Replimune Group Inc.
- Genelux Corporation
- Synthetic Biologics, Inc.
- Lokon Pharma AB
- Elicera Therapeutics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Oncolytic Virus Therapy Market, By Product Type
- Global Oncolytic Virus Therapy Market, By Application
- Global Oncolytic Virus Therapy Market, By Development Stage
- Global Oncolytic Virus Therapy Market, By Distribution Channel
- Global Oncolytic Virus Therapy Market, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Advancements in Viral Engineering
- Increasing Understanding of Cancer Biology
- Successful Clinical Trial Results
- Need for Innovative Cancer Treatments
- High cost associated with treatment
- Side effects of treatment
- Exploring new cancer indications
- Combining therapies for improved outcomes
- Personalized medicine approaches
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Oncolytic Virus Therapy Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Oncolytic Virus Therapy Market , By Product Type, 2020-2032, (US$ Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Herpes Simplex Virus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
- Adenovirus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
- Vaccinia virus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
- Reovirus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
- Measles virus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
- Others (Newcastle disease virus, Vesicular stomatitis virus)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
6. Oncolytic Virus Therapy Market, By Application, 2020-2032, (US$ Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Melanoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
- Breast cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,( US$ Mn)
- Head and neck cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,( US$ Mn)
- Bladder Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,( US$ Mn)
- Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,( US$ Mn)
- Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
- Others (Colorectal Cancer, and among Others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
7. Oncolytic Virus Therapy Market, By Development Stage, 2020-2032, (US$ Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Commercial
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
- Pipeline Phase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
- Pre-clinical
- Phase I
- Phase II
- Phase III
8. Oncolytic Virus Therapy Market , By Distribution Channel, 2020-2032, (US$ Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
9. Oncolytic Virus Therapy Market, By Region, 2020-2032, (US$ Mn)
- Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021-2032
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Development Stage, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Development Stage, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
- U.K
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Development Stage, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Development Stage, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Development Stage, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Development Stage, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Mn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Oncolytics Biotech Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Circio Holding ASA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Akamis Bio
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Vyriad, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- SillaJen Biotherapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cold Genesys Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sorrento Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Takara Bio Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Replimune Group Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Genelux Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Synthetic Biologics, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lokon Pharma AB
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Elicera Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
11. Section
- Research Methodology
- About us
관련자료
